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Summary 
Far, receptor-induced apoptosis plays critical roles in 
immune homeostasis. However, moet of the signal 
transduction events distal to Fas ligation have not 
been elucidated. Here, we show that Ras is activated 
following ligation of Fas on lymphold lines. The activa- 
tion of Ras is a crltlcal component of this apoptotic 
pathway, since inhibition of Ras by neutralizing anti- 
body or a dominant-negative Ras mutant interfered 
with Faslnduced apoptosis. Furthermore, ligation of 
Fas also resulted in stimulation of the sphlngomyelin 
signaling pathway to produce ceramides, which, in 
turn, are capable of inducing both Rar activation and 
apoptosls. This suggest8 that cemmides acts as sec- 
ond meseengem in Fas signaling via Ras. Thus, llga- 
tion of the Fas molecule on lymphocyte Ilnes induces 
activation of Ras vla the action of cemmide, and this 
activation is necessary, but not sufficient, for subse- 
quent apoptosls. I 
Introduction 
Apoptosis, or active cell death, is a process that occurs 
under a range of physiological and pathological conditions 
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in many different cell types, and is fundamental to the 
normal development of multicellular organisms (Kerr et 
al.,1972;Raff,1992;Wyllieetal.,196O).Fas/Apo-1 (CD95) 
is a welldefined cell surface receptor (Itoh et al., 1991; 
Oehm et al., 1992) of the tumor necrosis factor (TNF) re- 
ceptor superfamily (Smith et al., 1994). Its major function 
appears to be the induction of apoptosis in Fas+ cells, 
including activated lymphocytes and many transformed 
cells of hematopoietic lineages (Itoh et al., 1991; Cwen- 
Schaub et al., 1992; Trauth et al., 1969). Ligation of Fas 
by anti-Fas antibodies or its specific ligand rapidly induces 
apoptosis in vitro and in vivo (Itoh et al., 1991; Ogasawara 
et al., 1993; Trauth et al., 1969) and some cytotoxic T 
cells kill their targets in a calcium-independent manner 
via activation of Fas (Rouvier et al., 1993). Mutations in 
Fas (Watanabe-Fukunaga et al., 1992) or its ligand (Taka- 
hashi et al., 1994) are responsible for lymphadenopathy, 
lymphoaccumulation, and accelerated autoimmune da 
fects in Ipr and g/o homozygous mice, respectively. Ex- 
pression of a Fas transgene in T cells corrects the Ipr 
defect (Wu et al., 1994). Thus, Fas appears to play an 
important role in immune homeostasis. 
Despite a growing interest in apoptosis, relatively little 
is known about the molecular and biochemical basisof this 
process. Several molecules with roles in cell proliferation, 
including c-Myc (Askew et al., 1991; Evan et al., 1992; Shi 
et al., 1992) c-Fos (Colotta et al., 1992), and Cdc-2 (Shi 
et al., 1994) appear to have critical roles in the process 
of apoptosis under some conditions. This has led to the 
idea that cell proliferation and apoptotic cell death are 
intimately related. We therefore considered the possibility 
that Ras proteins, which play a central role in signaling 
pathways leading to cell activation and proliferation from 
multiple cell surface receptors (Satoh et al., 1992; Wil- 
liams, 1992), may also function in the Fas-initiated signal 
transduction pathway leading to apoptosis. Here, we dem- 
onstrate that Fas ligation induces Ras activation, and that 
this event is an important step in signaling for apoptosis. 
Further, the activation of Ras probably occurs via the 
sphingomyelin (SM) pathway, in which Fas ligation leads 
to ceramide production, which in turn activates Ras and 
subsequent apoptosis. 
Results 
Ligation of Fas Induces the Activation of Ras 
Human leukemic Jurkat T cells were treated with an anti- 
Fas monoclonal antibody (MAb) under conditions that re- 
producibly induced complete cell death within -12 hr, 
and the activity of immunoprecipitated Ras was evaluated 
by quantitating its guanosine 5’.triphosphate (GTP)-bound 
fraction. Fas ligation resulted in an increase in the fraction 
of active Ras from a resting level of 9.7% to 46% or 43.6% 
after 2 or 5 min of treatment, respectively (Figure 1A). As 
a positive control, ligation of the T cell receptor (TCR)- 
CD3 complex by an anti-CD3 MAb, which was previously 
found to cause Ras activation (Downward et at., 1990) 
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Figure 1. Activation of the Raa Signaling Pathway by Fae Ligation 
(A) Time comae of anti-Faa-mediated Rae activation in Jurkat cells. 
(6) MAP kinaee activation by anti-faa antibodies. lmmunoprecipitated 
MAP kinaae from anti-fae-treated Jurkat cells wae teeted for its ability 
to phoephorylate a substrate (MSP) in vitro. 
(C) Anti-Faa-induced Raa activation in murfne Ps15 cells expressing 
human Faa. Labeled cells were treated wfth anti-Fae for 5 min and 
immunoprecipitated Rae wae examined for associated GDP versus 
GTP. An increase in GTP indicates Rae activation. 
resulted in approximately a 4-fold increase in the level of 
Ras-bound GTP in Jurkat cells. Mitogen-activated protein 
(MAP) kinases, which are stimulated as a consequence of 
Rss activation in many cell types (Davis, 1993), including T 
cells (Izquierdo et al., 1993) were also activated following 
Fas ligation (Figure 1 B), providing further evidence that 
Fas can signal through the Ras pathway. 
To establish the specificity of Ras activation by the anti- 
Fas antibody, the human fas cDNA was stably introduced 
into murine P815 cells via retrovirus-mediated gene trans- 
fer. The fas-transfected cells (P815fas) but not the paren- 
tal cells expressed human Fas on their surface at levels 
equivalent or higher than those displayed by Jurkat cells 
(data not shown). Further, the P815fas cells underwent 
apoptosis when treated with anti-human Fas MAb, while 
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Figure 2. Rae Activation Is Required for Anti-FaeMediated Cell Death 
(A) Effect of rapnr7 transient expression on anti-Fae-induced DNA 
fragmentation. Jurkat cells were labeled with PH]TdR and transfected 
with CD20 plus either rail” or a vector control. After culture, CD20+ 
cells were selected using magnetic beads and anti-CD20 antibody. 
Cells (on the beads) were then culture$l f anti-Faa and the percentage 
of DNA fragmentation wae determined after s-4 hr of culture. Reaufta 
shown are the mean f SEM of four independent experiments. 
(6) lnhlbition of anti-faeinduced apopto& by microinjection of RasL”” 
or anti-Raa antibody. Jurkat cells or.Ps15.Faa cells were microinjected 
with Flee*“” protein, bovine serum albumin, anti-Raa (Yl3-259) or 
control rat IgG ae indicated, and then cultured with anti-Fae antibody. 
Subeequent apoptoais waa determined microecopically by morpho- 
logic critieria. Apoptotic cells displayed pronounced and unambiguous 
blebbing and fragmentation into apoptotic bodies. R*” veraus con- 
trol, p < 0.001. Y13 vereus control IgG, p < 0.001. 
(C) Inhibition of anti-Faa-induced DNA fragmentation by electropora- 
tion of anti-Rae antibody. Jurkat cells were labeled with PH]TdR and 
then electroporated with neutralizing anti-Rae (Y13-259) or control 
rat IgG aa indicated. Under the condiifons employed, leaa than 10% 
mortafity wae induced by the electroporation. Cells were then cultured 
f anti-Faa antibody and DNA fragmentation waa determined after 
approximately 4 hr. Similar results were obtained in a second experi- 
ment (data not shown). 
control P815 cells did not (data not shown). As in Jurkat 
cells, Fas ligation in P815.fas cells led to Ras activation, 
evidenced by a marked increase in Ras-GTP (Figure 1C). 
Thus, the activation of Ras following treatment of cells 
with anti-Fas MAb is a specific effect of Fas ligation. 
Ras Activation Is Required for Fas-Induced 
Cell Death 
To determine whether Fas-induced Ras activation is a 
obligatory event in the pathway leading to apoptosis, we 
employed a dominant-negative mutant of ras, rs~+~~, to 
block Ras activition. The ability of then?@” to block Ras- 
dependent signaling was confirmed in transient cotrans- 
fection assays using an interleukin-2 (IL-2) promoter- 
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chloramphenicol acetyltransferase (CAT) reporter gene 
construct, which is induced in activated Jurkat cells in a 
&s-dependent manner (Baldari et al., 1993). Cotransfec- 
tion with fafl” inhibited by - 80% the activation of this 
IL-2 promoter by either phorbol ester or anti-CD3 in Jurkat 
cells (data not shown). To assess the effects of the domi- 
nant-negative ra+17 on Fas-induced apoptosis, [3H]TdR- 
labeled Jurkat cells were transiently transfected with a trans 
dominant-negative ras expression vector (pEF/rasLU”“), 
or with a control vector (pEF) and cotransfected with a 
CD20 expression plasmid. The transfected cells were en- 
riched by positive immunoselection for CD20 expression, 
and their susceptibility to anti-Fas-mediated apoptosis 
was then determined by quantitative DNA fragmentation 
assays. Whereas the control vector-transfected cell popu- 
lation displayed 32.7% DNA fragmentation in response to 
Fas ligation, apoptosis-associated DNA fragmentation in 
the fas+n17-expressing population was reduced by - 80% 
(Figure 2A) under the same conditions (Student’s t test, 
p < 0.05). 
As a second approach, anti-Fas-induced death was as- 
sessed in Jurkat cells after microinjection with recombi- 
nant Rasb17 protein. Microinjection of RasLU”17 reduced 
Fas-induced apoptosis from 78% in the control groups 
to 44% (2 test, p < 0.001) (Figure 28). Then, as a third 
approach, we employed an inhibitory anti-Ras antibody to 
block Ras function. Microinjection of Y13-259 into Fas+- 
P815 cells (Figure 28) inhibited Fas-induced cell death by 
40% (x2 test, p < 0.001). Similarly, electroporation of this 
antibody into Jurkat cells (Figure 2C) completely inhibited 
Fas-induced DNAfragmentation, whereas electroporation 
of control immunoglobulin G (IgG) inhibited by only 18%. 
In other experiments (data not shown), electroporation of 
Y13-259 or another anti-Ras antibody similarly inhibited 
Fas-induced DNA fragmention, although usually this was 
not as complete an inhibition as shown here. 
Thus, inhibition of Ras appears to interfere with Fas- 
induced apoptosis, although in general we did not observe 
complete inhibition. We expect that this is due to the tech- 
nical difficulties in inhibiting Ras activation and the very 
powerful apoptotic signal delivered by Fas ligation. Never- 
theless, taken together, the results from these different 
approaches indicate that Ras activation participates in 
Fas-induced cell death. 
The inhibition of Ras activation blocks some but not all 
signalsgenerated by Fasligation. In theexperiment shown 
in Figure 3, we again employed transient expression of 
the dominant-negative rap” construct (plus CD20) to 
interfere with Fas-induced effects. As in Figure 2A, cells 
expressing CD20 following transfection were selected and 
treated with anti-Fas antibody. Again, expression of domi- 
nant-negative Ras inhibited DNA fragmentation associ- 
ated with apoptosis (Figure 3A). An aliquot of these 
transfected and selected cells were also examined for acti- 
vation of MAP kinase following Fas ligation. As shown in 
Figure 38, anti-Fas treatment induced elevated activity of 
immunoprecipitated MAP kinase in an in vitro kinase assay 
in cells transfected with vector alone (plus CD20), similar 
to the effect obsewed in Figure 1 B. This Fas-induced acti- 
vation of MAP kinase was partially reduced in cells that 
were transiently transfected with dominant-negative men17 
(Figure 38). In contrast, Fas-induced tyrosine phosphory- 
lation was relatively unaffected by expression of rsp”. 
As shown in Figure 3C, an anti-phosphotyrosine immu- 
noblot of transiently transfected and selected cells showed 
increased tyrosine phosphorylation of a variety of proteins 
following Fas ligation, as has been described by others 
(Eischen et al., 1994). While some differences were de- 
tected, most of these Fas-induced phosphorylation events 
were very similar in both groups of transfected cells. 
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Figure 3. Effects of Transiently Expressed Dominant-Negative Ras 
on Fas-Induced Signaling Events 
Jurkat cells were transiently transfectsd with CD20 plus either vector 
(pEF)orra+17, and then selected with anti-CD20 antibody as in Figure 
2A. All results shown in this figure were derived from the same pool 
of transiently transfected cells. 
(A) Fas-induced DNA fragmentation of transiently transfected PHjTdR 
cells. Cells were treated with anti-Fas antibody for 4 hr before as- 
sessing DNA fragmentation. 
(6) MAP kinase activation in transiently transfected cells. MAP kinase 
activity was determined as in Figure 18, 5 min after treatment with 
anti-Fas. 
(C) Tyrosine phosphorylation induced by Fas ligation in transiently 
transfected cells. Cells were treated with anti-Fas for 2 min. following 
which protein was extracted and analyzed by immunoblot with anti-p- 
tyr antibody (4610). 
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Figure 4. Stimulation of the SM Signaling Pathway by Anti-Fas Anti- 
bodies 
(A) SM consumption versus ceramide production in Jurkat cells treated 
with anti-Fas antibody. The results for SM and ceramide are represen- 
tative of four experiments. 
(B) Anti-Fas-stimulated ceramide production in human Fas-expressing 
P815 cells stimulated for 2 min with anti-Fas. Fas-Induced ceramide 
production in P815 cells is shown as a mean percentage of control 
f SEM from the number of independent experiments (n) shown for 
each cell line (in P815.fas cells, p < 0.005 for anti-Fas versus control). 
Fas Stimulates the SM Signaling Pathway 
Although very little is known about Fas-induced signals 
that might lead to apoptosis, two laboratories (Cifone et 
al., 1994; Gill et al., 1994) have provided evidence that the 
SM pathwayisactivated upon Fasligation. In this pathway, 
receptor ligation causes direct or indirect stimulation of a 
neutral or acidic SMase that results in hydrolysis of mem- 
brane SM to ceramide and phosphocholine. Ceramide 
then acts as a second messenger to stimulate several 
distinct biochemical events associated with cellular activa- 
tion (Kolesnick and Golde, 1994). Other recent studies 
have shown that stimulation of the tumor necrosis factor 
a (TNFa) receptor (p55TNFR) with its ligand results in acti- 
vation of the SM signaling pathway (Dressier et al., 1992; 
Kim et al., 1991; Wiegmann et al., 1992; Yanaga and Wat- 
son, 1992) and synthetic ceramides can induce apoptosis 
in some cell lines (Jarvis et al., 1994; Obeid et al., 1993). 
Since both TNFR and Fas are members of the TNF recep 
tor family capable of inducing apoptosis, the activation of 
the SM signaling pathway by these receptors is likely to 
be important. 
As shown in Figure 4, we confirmed that Fas ligation 
stimulates SM consumption and increased ceramide pro- 
duction in [3H]choline-labeled Jurkat cells (Figure 4A). Fas 
ligation induced a rapid decrease in the level of SM from 
1,000 to 730 pmolll08 cells within 1 min of stimulation 
(Figure 4A). In three independent experiments, SM levels 
were decreased by an average of 26% f 6% after 1 min 
of Fas ligation (data not shown). In parallel, the level of 
the hydrolysis product of SM, ceramide, increased nearly 
quantitatively from 250 to a maximum of 440 pmol/lO 
cells (Figure 4A). Increased ceramide levels were detected 
as early as 30 s after addition of anti-Fas (n = 3, p < .02 
versus control), and as little as 1 @ml of anti-Fas was 
found to be effective (data not shown). As shown in Figure 
48, anti-Fas also stimulated ceramide production from 
P615fas cells. Values shown in the figure are for 2 min 
of stimulation, although significant ceramide release was 
observed after 30 s of stimulation as well (data not shown). 
The magnitude and duration of these biochemical 
changes were similar to the reported effects of TNFa or 
IL-1 stimulation (Ballou et al., 1992; Mathias et al., 1993; 
Schiitze et al., 1992; Wiegmann et al., 1992; Yang et al., 
1993). 
In the experiment shown in Figure 3, in which transient 
expression of dominant-negative Ras interfered with the 
induction of Fas-induced apoptosis, we also examined SM 
hydrolysis in the selected cells (data not shown). We found 
that Fas-induced loss of labeled SM from the membranes 
was not significantly different in the cells transfected with 
vector versus those transfected with raen17 (31.5 f 9% 
versus 23.5 f 6% reduction, respectively; difference not 
significant). Thus, it appears likely that the activation of 
Ras is downstream of Fas-induced SM hydrolysis. 
Synthetic Ceramldes Mimic Events Induced 
by Fas Ligation 
The rapid stimulation of the SM pathway by Fas ligation 
suggested the possibility that ceramides produced as a 
consequence of SM hydrolysis serve as second messen- 
gers in the pathway leading from Fas ligation to cell death. 
Synthetic ceramides have been shown to induce apop 
tosis in several cell lines (Jarvis et al., 1994; Obeid et al., 
1993). In the experiments shown in Figure 5A, we con- 
firmed that exogenously added synthetic ceramides in- 
duce apoptosis in Jurkat cells. Addition of N-acetyl sphin- 
gosine (C2-Cer) or N-hexanoyl sphingosine (C6Cer) to 
cultured Jurkat cells induced DNA fragmentation and ex- 
tensive apoptosis, as determined by cell morphology (Fig- 
ure 5A). As controls, OAG, an analog of the protein kinase 
C-activating diacylglycerol (DAG), and dihydro-C2cera- 
mide did not induce apoptosis (Figure 5A). Similarly, ara- 
chidonic acid (20 ug/ml) had no ability to induce apoptosis 
(data not shown). 
If ceramide acts as a Fas-induced signal for apoptosis, 
it might be responsible for the activation of Ras we ob- 
sewed. Synthetic ceramkfes readily enter cells and can 
reach detectable intracellular levels within seconds (Younes 
et al., 1992) and therefore we examined the effects of these 
agents within 2-5 min of addition. We observed that syn- 
thetic ceramides stimulated the activation of Ras (Figure 
58) and MAP kinases (Figure 5C), as did the anti-Fas MAb 
(although in the latter case, activation of MAP kinases was 
more pronounced with Fas ligation). Activation of MAP 
kinases by ceramide has also been described by others 
(Raines et al., 1993). Ras was not activated by dihydrocer- 
amide, although it was activated by phorbol ester, as ex- 
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Figure 5. Synthetic Ceramides Mimic Some Effects of Fas Ligation 
(A) Induction of DNAfragmentation and apoptoticmorphology in Jurkat 
cells. PHjthymidinalabeled and washed Jurkat cetls were stimulated 
for 18hr(inthepresenceof 5%fetalcalfaerum)wtth lCOng/mlantllFas 
MAb, 20 )IM each C2-Cer, dihydroC2Cer (DHC2Cer), or CB-Cer (Bio- 
mol) and DNA fragmentation versus apoptotic morphology was deter- 
mined. Apoptosis was assessed by staining with acridine orangelethid- 
ium bromide and fluorescence microscopy as described (Duke and 
Cohen, Iggl). The results are expressed as mean f SD of triplicate 
cuJtures. 
(B) Induction of Ras activation. Labeled Jurkat cells were treated for 
5 min with anti-Fas, C2-Cer, DHC2Cer. or phorbol myristate acetate, 
and Ras activation was determined as in Figure IC. In independent 
experiments, CbCer was similarly obsewed to activate Raa (data not 
shown). 
(C) Induction of MAP kinase activity by synthetic ceramides. Jurkat 
cells were left untreated or stimulated for 5 min with 2 @ml anti-Fas 
antibody, or 5 CM each C2Cer or CB-Cer. Lysis, immunoprecipitation, 
and determination of the activity of MAP kinase were performed as 
for Figure 1 B. 
petted (Figure 58). Ras activation by C8-Cer was seen in 
other experiments (data not shown). Thus, Fas ligation 
induces the hydrolysis of SM to form ceramide, and cera- 
mide is capable of activating both Ras and apoptosis. It 
seems likely, then, that a pathway leads from Fas to cera- 
mide to Ras, and that this pathway forms a subset of Fas- 
induced signaling events that lead to apoptosis. 
To test the last idea, we asked whether the activation 
of Ras by ceramide contributes to its ability to induce 
apoptosis. We therefore performed the experiments 
shown in Figure 8, in which anti-Ras antibody was intro- 
duced into Jurkat cells byelectroporation. This wassimilar 
to the method used in the experiments in Figure2C except 
that a different anti-Ras antibody was employed (142- 
24E5) (Chesa et al., 1987). This MAb was raised against 
a synthetic peptide corresponding to residues 98-l 18 of 
H-Ras, a highly consenred region that has been implicated 
in guanine nucleotide binding (Pai et al., 1989). The ability 
of the electroporated antibody to block the Ras signaling 
cascade in T cells was confirmed in the experiment shown 
in Figure 8A. Electroporation of Jurkat cells with this anti- 
Ras antibody but not a control IgG interfered with the acti- 
vation of MAP kinase following ligation of CD3, a Ras- 
dependent event in Jurkat cells (Izquierdo et al., 1993). 
As we saw with theY13-259 antibody(Figure2C), electro- 
poration of Jurkat cells with 142-24E5 consistently inter- 
fered with the ability of Fas to induce DNA fragmentation 
(Figure 8s). This effect was blocked by coelectroporation 
of the cells with anti-Ras and the Ras peptide to which 
the antibody binds. Finally, we examined the effect of elec- 
troporation of this anti-Ras antibody on ceramidbinduced 
apoptosis. As shown in Figure 8C, electroporation with 
anti-Ras blocked the induction of DNA fragmentation by 
C8-Cer, and this was effectively competed by coelectro- 
poration with the specific peptide. These results strongly 
support the idea that Ras activation participates in cera- 
mide-induced apoptosis. Further, they support the above 
proposal that Fas induces Ras activation and apoptosis 
at least in part via the activation of ceramide. 
Discussion 
Ligation of the cell surface Fas molecule rapidly and dra- 
matically induces apoptosis in many cell types. In Jurkat 
cells, this process begins approximately 2-4 hr after expo 
sure to cross-linking anti-Fas antibody. We have identified 
Ras activation that occurs within minutes of Fas ligation as 
a critical component of the Fas-initiated pathway leading 
to apoptosis. Transient expression of dominant-negative 
IC)&“‘~~ or microinjectiin of the RasLU”17 protein inhibited 
Far+induced apoptosis. Further, either microinjection or 
electroporation of a neutralizing antiiRas antibody also 
inhibited Fas-lnduced apoptosis. Thus, Ras appears to funo 
tion at an essential step in the signal transduction path- 
way induced by Fas and culminating in apoptosis. In gen- 
eral, the inhibition of apoptosis we observed by any of 
the Ras-neutralizing strategies was partial; that is, some 
apoptosis usually occurred in the presence of Ras*“” or 
neutralizing antidas antibody. We expect that this is due 
to a partial inhibition of Ras activation, although we cannot 
exclude the possibility that other Ras-independent path- 
ways of Fas-induced apoptosis may be functional. 
Wyllie and colleagues (1987) examined the effects of 
elevated c-ras expression in fibroblasts and observed an 
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increased rate of both proliferation and apoptosis in these 
versus the parental cells. In contrast, this group also found 
that cells expressing a mutated constitutively active form 
of as exhibited elevated levels of proliferation and de- 
creased levels of apotosis, suggesting that some activated 
mutants of ms can interfere with apoptosis. More recently, 
Tanaka et al. (1994) described experiments in which acti- 
vated Ras promoted apoptosis in embryonic fibroblasts 
and found that this effect appears to be dependent upon 
expression of the transcription factor IRF-1. Other than 
these reports, we are not aware of studies implicating a 
direct role for Ras in the induction of apoptosis. Neverthe- 
less, it is likely that Ras plays a role in other pathways 
leading to apoptosis. For example, TCR-CD3 ligation, 
which leads to Ras activation in mature T cells (Downward 
et al., 1990), induces apoptosis in immature thymocytes 
or T cell hybridomas (Green and Scott, 1994). It is not 
unlikely that these phenomena are linked. 
In addition to Ras activation, Fas ligation also stimulated 
the SM signaling pathway, a pathway that was recently 
found to mediate signaling from stimulated receptors for 
IL-1 (Ballou et al., 1992; Mathias et al., 1993) and TNFa 
(Schlltze et al., 1992; Wiegmann et al., 1992; Yang et 
al., 1993). Recently, the SM signaling pathway has been 
shown to be stimulated by-r irradiation, which also induces 
apoptosis under the same conditions (Haimovitz-Fried- 
man et al., 1994). With regard to Fas-induced activation 
of this pathway, Cifone and colleagues (1994) and Gill et 
al. (1994) have recently reported the activation of SM and 
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Figure 6. Inhibition of Ras Activation Inter- 
feres with Ceramidalnduced Apoptosis in Jur- 
kat Cells 
(A) Jurkat cells were electroporated with anti- 
Ras (142-24E5) or control IgG (GAP3.3) and 
then treated with anti-CD3 antibody for 5 min. 
MAP kinase was precipitated and its activity 
tested as in Figure 1. 
(8) Electroporation wfth anti-Ras interfereswith 
Fas-induced apoptosis. Jurkat cells were la- 
beled with PHJTdR and then electroporated as 
in (A). In some experiments, the anti-Ras anti- 
body was preincubated with its antigenic pep 
tide (Ras peptide). Cells were then treated with 
33 rig/ml of anti-Fas and DNA fragmentation 
was assessed after 4 hr. The number of inde 
pendent experiments for each group is indi- 
cated. 
(C) Cells were labeled and electroporated as 
in (B), and then cultured with C5-Cer (5 @ml). 
DNA fragmentation was assessed after 4 hr. 
ceramide production upon Fas ligation. The extent of acti- 
vation they obsenred is consistent with that observed by 
us. Our results point to an important role of this signaling 
pathway in Fas-initiated apoptosis by demonstrating that 
it is stimulated rapidly (within 30 s) by Fas ligation and a 
product of this pathway (ceramide) was found to mimic 
the biological events stimulated by Fas ligation, i.e., acti- 
vation of Ras and MAP kinases and the induction of 
apoptosis. Titration experiments indicated that the con- 
centration of anti-Fas MAbs required to stimulate the SM 
pathway and that required to induce apoptosis were in the 
same range (data not shown), providing further evidence 
that these are linked processes. Other recent studies have 
similarly implicated ceramides in triggering apoptosis. The 
TNFa receptor, which is structurally related to Fas (Smith 
et al., 1994) was found to stimulate the SM signal trans- 
duction pathway (Schutze et al., 1992; Wiegmann et al., 
1992; Yang et al., 1993). Synthetic ceramides or exoge- 
nous SMase can induce apoptosis in several cell types 
(Jawis et al., 1994; Obeid et al., 1993) and activate Vav 
in vitro (Gulbins et al., 1994) and MAP kinases in vivo 
(Raines et al., 1993). Our findings support a role for cera- 
mide in Fas-induced apoptosis and relate the signaling 
events that follow Fas ligation and exposure to ceramide. 
Ras is activated by the exchange of bound guanosine 
5’diphosphate (GDP) for GTP, which can occur as a result 
of reduction in the activity of Ras GTPase-activating pro- 
teins (GAP). Such a mechanism accounts, in part, for Ras 
stimulation following TCR-CD3 ligation in T cells (Down- 
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Figure 7. Schematic Representation of the Role of Ras and Cera- 
mides in Fas-Induced Signaling Pathways Leading to Apoptosis versus 
(3rowMDifferentiation 
We propose that the ability of Fas or ceramide to induce either 
apoptosis or growth (or differentiation) is consistent with a central role 
for Ras in Fas and ceramide signaling, with the outcome determined 
by other signals. 
ward et al., 1990). However, we were unable to detect 
a decrease in GAP activity in total cell lysates or GAP 
immunoprecipitates from Fas-stimulated Jurkat cells, 
while under similar conditions, antiCD3 ligation caused 
a decrease in GAP activity within 5 min (data not shown). 
As an alternative mechanism of Ras activation, the effects 
of Fas ligation may be mediated through stimulation of a 
guanine nucleotide exchange factor. 
Tyrosine kinases may also be involved in the signal 
transduction pathways. Recently, a requirement for tyro- 
sine kinase activation in Fas-induced apoptosis was sug- 
gested (Eischen et al., 1994) although this finding is con- 
troversial (Schutze-Osthoff et al., 1994). Nevertheless, 
Fas ligation affects the profile of tyrosine phosphorylation 
(Eischen et al., 1994) and we have obsenred that some, 
but not all, of these events are affected by expression of 
dominant-negative ras (Figure 3). One such downstream 
event is likely to be the phosphorylation and activation of 
MAP kinase. Thus, some tyrosine kinases may function 
upstream and others downstream of Ras activation follow- 
ing Fas ligation. However, unlike the effects of antiCD3, 
we observed that anti-Fas did not cause any detectable 
increase in the intracellular Caz+ concentration (data not 
shown), an event that can follow tyrosine kinase activation 
in T cells (June et al., 1990a, 1999b). 
Our results indicating an important role for Ras in the 
process of Fas-induced apoptosis appear paradoxical 
given the critical role of Ras in a number of signals that 
promotecell survival, proliferation, differentiation, or some 
combination of the three. For example, a number of growth 
factors are known to have anti-apoptotic effects on cells 
(Raff, 1992) and many of these growth factors signal via 
Ras (Satoh et al., 1992; Williams, 1992). Figure 7 shows 
a simple model to account for Ras involvement in Fas- 
or ceramide-induced apoptosis. In this model, the initial 
signal triggers two pathways: one pathway involves Ras 
activation, which in turn directly or indirectly gives a posi- 
tive signal for the continuation of a second pathway, which 
results in apoptosis. In this scenario, Ras activation by 
itself is necessary but not sufficient for induction of 
apoptosis. This would explain why only some agents that 
stimulate Ras, i.e., anti-Fas antibodies and ceramide, but 
not a number of others, e.g., phorbol esters, are capable 
of inducing apoptosis. The nature of the second signal 
or pathway that is required for Fas-induced apoptosis is 
currently undefined. Two receptors capable of inducing 
apoptosis, i.e., the p55TNFR and Fas, activate the SM 
signaling pathway, and it is tempting to propose that cera- 
mides may function as critical second messengers in this 
second pathway. In this regard, two ceramide-activated 
enzymes have been found. They include an undefined 
prolinedirected serinelthereonine kinase (Dressler et al., 
1992; Joseph et al., 1993; Mathias et al., 1993) and phos- 
phatase 2A (Dobrowsky et al., 1993). 
However, the cytoplasmic regions of p55TNFR and Fas 
induce apoptosis with strikingly different kinetics (Clement 
and Stamenkovic, 1994) and with different pharmacologic 
sensitivities (Schutze-Osthoff et al., 1994; Wong and 
Goeddel, 1994). Therefore, even if ceramide is a critical 
component of the apoptotic signal generated by ligation of 
either of these receptors, additional independent signals 
probably play roles in inducing apoptosis, and these addi- 
tional pathways may be different for these two receptors. 
Thus, in Figure 7, we leave the possibility open that signals 
other than those involved in activating the SM pathway 
play roles in Fas-induced apoptosis. 
The induction of apoptosis is not an inevitable conse- 
quence of Fas ligation or exposure to ceramide. Fas liga- 
tion can give a positive signal that leads to enhanced prolif- 
eration during T cell activation (Alderson et al., 1993; 
Maparaet al., 1993). Similarly, phorbol estersor DAG have 
been shown to interfere with ceramide-induced cell death 
(Jarvis et al., 1994; Obeid et al., 1993). Further, ceramide 
is known to induce proliferation, differentiation, or both in 
some cells (Olivera et al., 1992) in addition to its ability 
to induce apoptosis. Such observations support the model 
shown in Figure 7, in which additional signals to the cell 
open a pathway that is facilitated by Ras activation (e.g., 
induced by Fas or ceramide). In turn, this pathway inhibits 
the apoptotic pathway stimulated by Faslceramide. These 
ideas are reminiscent of similar considerations concerning 
the ability of c-Myc (and other growth-promoting proteins) 
to function in the induction of apoptosis. 
Why are signals leading to proliferation versus apoptosis 
so intimately associated? In multicellular organisms, the 
ability of a single cell to proliferate can compromise the 
integrity of the individual and, therefore, extrinsic controls 
on cell proliferation versus cell death are of critical impor- 
tance. We (Bissonnette et al., 1994) and others (Evan et 
al., 1992) have suggested that activation of c-Myc essen- 
tially opens two possibilities to the cell: divide or die. The 
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outcome is determined by other signals, such as those 
provided by growth factor receptors or oncogenes. Our 
results with Ras suggest that this protein might have a 
similar ability to influence both cell survival and cell death 
pathways. The identification of a defined signal transduc- 
tion pathway involved in Fas-mediated apoptosis at the 
biochemical level opens the way to additional studies 
aimed at elucidating the molecular details of this funda- 
mental biologic process. 
Experimental Pmcedures 
Ceil Lines 
Jurkat was obtained from the American Type Culture Collection and 
maintained in RPM1 1640 medium (GIBCO) supplemented with 10% 
fetal bovine serum (Irvine Scientific). 
Murlne P815 ceils expressing human Fas/CD95 were generated as 
follows. The human CD95 cDNA clone AP014.2 (Oehm et al., 1992) 
was subcloned into the EcoRl site of pLXSN 90 (Miller and Rosman, 
1989) by standard recombinant DNA techniques. pLXSN-APO-1 
(pLRCASN) was electroporated (250 V, 960 sF) into the ecotropic 
retrovirus packaging line, y2, which was then cocukured with the am- 
photropic retrovirus packaging line, PA317, for 2 weeks as described 
(Bestwick et al., 1988). P815 ceils expressing Fas (P815fas) were 
made by coculture of P815 cells with y2/PA317-LRcASN cells over- 
night with 8 pg/ml poiybrene. Infected P815 cells were selected in 400 
pg/ml 6418 (GIBCO BRL) for 7 days. Fas surface expression and 
susceptibility to Fas-induced apoptosis were determined as detailed 
below. 
Far immundluorescsnce and Facinducsd Apoptosis 
Cells (1 x 106) were stained using mouse anti-human Fas IgG MAb 
(clone UB2, Kamiya Biomedical Company) followed by a fluorescein 
isothiocyanate-conjugated F(ab), fragment of goat anti-mouse im- 
munogtobuiin (Jackson lmmunoresearch Laboratories, West Grove, 
Pennsylvania) and analyzed on a FACScan. For induction of apoptosis, 
cells were cultured overnight with 100 @ml of anti-human Fas IgM 
(clone CH-11; Kamiya Biomedical Company) and apoptosis was as- 
sessed by acridine orangelethidium bromide staining and fluores- 
cence microscopy as described (Duke and Cohen, 1991). Apaptotic 
cells showed pronounced membrane biebbing, condensed and often 
fragmented nuclei, and, in later stages, loss of membrane integrity. 
Messummsnt of Ras Activation 
Jurkat cells (2 x lO’/group) were washed twice in phosphate-free 
RPM1 medium containing 10% dialyzed fetal bovine serum, resus- 
pended in the same medium, and labeled for 4 hr with 2 mCi/ml “Pi. 
Labeled cells were then treated with anti-Fas MAb (clone CH-11; Kam- 
iya Biomedical Company) (2 @ml) for the indicated time, or with anti- 
CD3 MAb (OKT3, 10 @ml) (5 min of stimulation), or left untreated. 
Stimulation was terminated by lysis in 25 mM Tris-HCI @H 7.5) 1% 
Triton X-100,20 mM MgCI,, 150 mM NaCI, 100 pg each aprotinin and 
ieupeptin. The nuclei were removed by 5 min of centrifugation at 
12000 x g and iysates were brought to 500 mM NaCi, 0.05% SDS, 
and 0.5% sodium deoxycholate (iysis buffer). The fraction of GTP- 
bound Ras was determined asdescribed (Downward et al., 1990; Gul- 
bins et al., 1994). In brief, Ras was immunoprecipitated for 45 min at 
4OC with 6 pl anti-Ras ascites (MAb 142-24E5), followed by addition 
of goat anti-mouse immunoglobulinconjugated agarose beads for an 
additional 45 min. Precipitates were washed eight times with lysis 
buffer and bound nucieotides were eluted with 0.2 ml 20 mM EDTA 
containing 25 nM each unlabeled GDP and GTP at 68OC. The eluate 
was analyzed by anion exchange high pressure liquid chromatography 
(Hagemeier et al., 1982). and GDPlGTP peaks were detected by att 
sorption at 268 nM and comparison with standards. Labeled nucleo- 
tides were determined by liquid scintillation counting, which was then 
used to calculate GTP/(GDP plus GTP) ratios. Experimental counts 
were between 300 and 800 cpm, and background counts (70-90 cpm) 
in control immunopreclpitates (prepared with an irrelevant mouse as- 
cites) were subtracted. The results represent the mean f SEM of 
four separate experiments. 
Alternatively, Ras was immunoprecipkated from P815 cells stimu- 
lated wlth anti-Fas (2 pg/mi) for 5 min as described above. immunopre 
cipitation was carried out with 4 ug rat anti-Ras MAb Yl3-259 (Onto 
gene Science, incorporated) followed by addition of rabbtt anti-rat 
immunoglobuiinconjugated agarose beads for an additional 46 min. 
After washing, bound nucieotides were eiuted as described above. 
The samples were centrifuged at 12000 x g for 5 min. nu&otMes 
in the supernatant were separated on PEi-cetlubse plates (Merck, 
Federal Republic of Germany), with 0.75M KzHPC, @H 3.5) and sub 
radiography was performed. 
Dstefminstion ot MAP Kinna Activstkn 
To measure MAP kinase activity, ceils (2 x lp/group) were washed 
twice, resuspended in a 10 mM HEPESNatine buffer @H 7.3), and 
stimulated at 37OC for the indicated times with 2 u@mi anti-human Fas 
MAb (clone CH-1 I; Kamiya Biomedical Company) or teft untreated. 
Stimulation was terminated by iysis in 50 mM HEPES buffer @H 7.5) 
containing 150 mM NaCi, 2% NP-40, phosphataee inhibitors (IO mM 
each NaF and NasVO,), 10 mM EDTA, 10 mM sodium pyrophoaphate, 
and 20 sg/ml each aprotinin and ieupeptin (lysis buffer). Ctarifted ty- 
sates representing equal cell numbers and protein wncentrations 
were immunoprecipitated with an anti-MAP kinase MAb (Zymed) reac- 
tive with both Erkl and Edc2, fotlowed by agarose-conjugated goat 
anti-mouse IgG. Washed immunoprecipitates were resuspended in 32 
pl kinase buffer (25 mM HEPES [pH 7.4],2 mM DTT, IO mM Mgt&) 
containing 20 ug myeiin basic protein (MBP; Sigma), and the kinase 
reaction was initiated by adding 10 uM [YpPjATP (40 CVmmd; Amer- 
sham). Samples were Incubated at 30°C for 10 min and the reaction 
was terminated with 8 pi of hot SDS, 2-mercaptoethanoi sample buffer 
(5 x), followed by SDS, 15% PAGE, and autoradiography (Guibins et 
al., 1994). 
Tmnsient Expression oi Dominant Negstive rss-’ 
Jurkat cells (20 x 109 in 0.4 ml complete RPM1 1840 medium were 
equilibrated on ice, and wtransfected by eiectroporation with 40 pg 
~EFlras*“‘~ or control @EF)52, plus 8 pg pCMV-CD20 (purified plae 
mid DNAs) using a BioRad electroporator (310 V, 960 pF). cells were 
kept on ice for an additional 15 mitt, diluted into 5 ml complete culture 
medium, and labeled by addition of 20 uCttmi PHJthymldine (8 Ct 
mmol; New England Nuclear) and culturing overnight. Viable-cells 
were purified by Ficdl gradient centrlfugation, and CD2tI+ ceils were 
positively selected by incubation (1 hr at 4OC) with an anti-CD20 MAb 
(50 ug/mi; Pharmingen), washing to remove excess antiCD20, and 
threesuccesslvecyclesof incubation(1 hrat4°C)withmagneticbeads 
(Dynal) coated with a sheep anti-mouse antibody. The efftcfency of 
this enrichment process is indicated by the finding that, in a typical 
experiment, 9,000 cpm of labeled CDPO-transfected ceils were bound 
to the beads, as compared with 520 cpm of control (non-CD20 
transfected) cells. Cells were then cultured in 96weii tissue culture 
plates (l-2 x 1Q cells/well), and stimulated for 3-4 hr wlth anti-Fas 
(100 @ml). Cells were disrupted by one cycle of freezing at -70°C 
and thawing. DNA fragmentation was then quantttated as described 
(Matzinger, 1991). Labeled high molecularweight unfragmented geno- 
mic DNA was collected by filtration through glass fiber ftlters (Phar- 
macla). and determined by liquid scintillation counting. Resufts are 
expressed as percent of DNA fragmentation * SD. DNA fragmenta- 
tion was calculated as follows: 
% fraomentation - 
cpm in control (unstimulated) iroup -cpm in stimulated group 
cpm in wntrol (unstimulated) group 
x ,oo 
Mkminjection 
For microinjection, Jurkat ceils were centrifuged onto glass grids (Ep- 
pendoff) coated with poly+lysine and, just prior to microinjection, 
0.1% fetal bovine serum was added to reduce ceil spreading. Cells 
were microinjected for 0.1 s at approx 15 hPa of pressure (Eppendorf 
Microinjector 5242) with recombinant Ra@17 protein (approximately 
1.5 mglml), or with 1% bovine serum albumin. Alternativefy, P815.fas 
cells were cultured on glass grids and were microinjected with purified 
antibody(Y13-259orwntrol immunogiobulin,2mglmi).Allceiiswlthin 
a defined area were injected. The ability of Y13-269 to block Ras 
function in microinjected ceils has been described (Mulcahyet al., 
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1965). Anti-Fas antibody was then added to the microinjected cells 
and the cells were microscopically examined for apoptosis after ap 
proximately 6 hr. At least 150-260 cells were assessed for each condi- 
tion. Apoptotic cells were readily discriminated by extensive blebbing 
and fragmentation into apoptotic bodies. 
Electropomtfon of Antlbodles 
Y13-259 hybridoma cells were obtained from the American Type Cul- 
ture Collection and antibody was purified from culture supernatants 
by protein A-affinity chromatography in high salt (Ey et al., 1976). 
Alternatively, another anti-&s MAb (142-24E5) or a control IgG 
(GAP6.3) were employed as ascites. In some cases, the 142-24E5 
antibody was incubated for 1 hr at 4OC with its specific peptide 
(H-Ress,,,, 1 mglml). Prior to electroporation, Jurkat cells (5 x IOr) 
were labeled overnight in 20 pCi/ml PHjthymidine. Electroporation with 
antibody was then performed essentially as described (Berglund and 
Starkey, 1991). Cells were washed twice in Hanks balanced salt solu- 
tion, resuspended in the same medium (400 sl) containing antibody 
(100 ul, 2 mg/ml), electroporated with 125 uF, 420 V and then trans- 
fered to RPM 1640.10% fetal calf serum. After 60 min at 37OC, recov- 
ered cells were eliquoted in 96-well plates and incubated with anti-Fas 
(109 @ml) or left untreated. DNA fragmentation was calculated as 
above from triplicate cultures and the values represent mean f SD. 
Detemhation of Sphlngomyelin and Cemmlde 
Cells in complete RPM1 1640 medium were labeled for 46 hr wfth 
1 pCi/ml [methyi-SH]choline chloride (60-90 Ctmmol; New England 
Nuclear). After three washes in Hanks balanced saft solution, 10 x 
I@ cells were resuspended in 50 ul Hank’s balanced salt solution 
and stimulated with 2 &ml anti-Fas MAb for the indicated times. 
Stimulation was terminated by adding 0.12 ml of 0.22 M HCI, 2.7 ml 
CHCls:CHsOH (2:l v/v). 0.9 ml of CH&I, and 0.9 ml of 1 M KCI. After 
mixing and centrifugation (15 min, 600 x g), the organic phase was 
collected, dried, resuspended in CHCI:CHSOH (I:1 v/v), and sepa- 
rated on G60 silica gel thin layer chromatography plates (Brinkmann) 
using a sofvent system consisting of CHClS:CHsOH:H20:acetic acid 
(5030:6:4. v/v). SM was identified by running in parallel an BM stan- 
dard (Sigma), and the radioactivity in the SM peak was determined by 
liquid scintillation counting. SM masswasdetermined byphospholipid 
phosphorus measurements (Rebecchi et al., 1963). 
Ceramide content was determined by the DAG kinase reaction as 
previously described (Younes et al., 1992). In brief, portions of the 
ceramide-containing organic phase were dried under nitrogen and 
solubillzed by bath sonication into 20 pl of 7.5% n-octyl-6-o- 
glucopyranoside, 5 mM cardiolipin, and 1 mM DETAPAC. Thereafter, 
20 pl of reaction mixture (250 mM Tris-HCI. 509 mM NaCI, 10 mM 
EGTA, 25 mM Mg2* [pH 7.01) and 3.5 pg of purified Escherichia coli 
DAG kinase (Calbiochem) in 40 ul of enzyme buffer (20 mM Tris-HCI, 
1.0 mM DTT, 1.5 M NaCI, 250 mM sucrose, 15% glycerol [pH 7.41) 
were added. The reaction was started by addition of 20 ul of 10 mM 
[~P]ATP(1OOOdpm/pmol)inenzyme bufferandstopped byextraction 
of lipids with 1 ml of chloroform: methanol: concentrated HCI (100: 
100:1 v/v/v), 170 plof balancedsalt solutionand plof IOOmM EDTA. 
The lower organic phase was dried under nitrogen and ceramide l- 
phosphate resolved by TLC using CHCls:CHsOH:acetic acid (65:15: 
5, v/v) as solvent, visualized by autoradiography, and quantified by 
liquid scintillation counting. Ceramide content of samples was deter- 
mined by comparison to a standard curve comprised of known quanti- 
ties of ceramide (Sigma). 
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